SGC-CK2-1 T40131

Product Introduction
Bioactivity


英文名: SGC-CK2-1

描述: SGC-CK2-1 is an ATP-competitive chemical compound that acts as a highly potent and cell-active CK2 inhibitor. It demonstrates excellent selectivity towards both isoforms of human CK2, with IC50 values of 36 nM for CK2α and 16 nM for CK2α′ in the nanoBRET assay. Given its properties, SGC-CK2-1 is a suitable tool for the investigation of neurodegenerative diseases.

体外活性: SGC-CK2-1 inhibits CSNK2A2 and CSNK2A1 with IC 50 s?value of 2.3 and 4.2 nM[1]. SGC-CK2-1 inhibits DYRK2 with the IC 50 value of 3.7 μM[1]. SGC-CK2-1 inhibits blood U-937, MV4-11, MOLM-13, OCI-LY19, OCI-AML5 cells with IC 50 s of 120, 690, 750, 760 and 810 nM, respectively. SGC-CK2-1 inhibits Head/Neck Detroit562 cells with an IC 50 of 550 nM. SGC-CK2-1 inhibits Lung NCI-H2286 cells with an IC 50 of 550 nM. SGC-CK2-1 inhibits Brain SK-N-MC cells with an IC 50 of 730 nM. SGC-CK2-1 inhibits Breast BT-20 cells with an IC 50 of 810 nM. SGC-CK2-1 inhibits Skin A375 cells with an IC 50 of 830 nM. SGC-CK2-1 inhibits Stomach SNU-1 cells with an IC 50 of 860 nM. SGC-CK2-1 inhibits Duodenum Hutu 80 cells with an IC 50 of 920 nM[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: SGC-CK-2-1 | SGCCK21 | SGC CK2 1

SGC-CK2-1 T40131信息由TargetMol中国为您提供，如您想了解更多关于SGC-CK2-1 T40131报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途